• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Decade of Non-Invasive Prenatal Testing (NIPT) for Chromosomal Abnormalities in Croatia: First National Monocentric Study to Inform Country's Future Prenatal Care Strategy.克罗地亚十年无创产前检测(NIPT)用于染色体异常检测:为该国未来产前护理策略提供信息的首个全国单中心研究
Genes (Basel). 2024 Dec 11;15(12):1590. doi: 10.3390/genes15121590.
2
The value of increasing sequencing depth for noninvasive prenatal screening for whole chromosomal aneuploidy.增加测序深度用于全染色体非整倍体无创产前筛查的价值。
Sci Rep. 2025 Jan 21;15(1):2673. doi: 10.1038/s41598-025-87218-x.
3
Combined first-trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT.孕早期联合筛查与非典型染色体畸变的侵入性诊断:丹麦全国范围内关于产前特征及检测与无创产前检测对比的研究
Ultrasound Obstet Gynecol. 2024 Oct;64(4):470-479. doi: 10.1002/uog.27667. Epub 2024 Sep 4.
4
Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.在国民医疗服务体系地区遗传学实验室中实施基于游离DNA的无创产前检测
Genet Res (Camb). 2019 Dec 9;101:e11. doi: 10.1017/S0016672319000119.
5
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.在中国一个试点城市,非侵入性产前检测在 21 三体、18 三体、13 三体和性染色体非整倍体的一线筛查中表现出良好的临床性能。
Hum Genomics. 2020 Jun 5;14(1):21. doi: 10.1186/s40246-020-00268-2.
6
[Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].母体外周血游离胎儿DNA产前检测的回顾性分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2023 Aug 10;40(8):933-938. doi: 10.3760/cma.j.cn511374-20220815-00545.
7
Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.常规临床实践中的无创产前检测——对澳大利亚未选择人群中无创产前检测和孕早期联合筛查的一项审计
Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):22-8. doi: 10.1111/ajo.12432.
8
Effect of maternal age on foetal chromosomal defects: an investigation based on non-invasive prenatal testing.母亲年龄对胎儿染色体缺陷的影响:基于无创产前检测的调查
J Obstet Gynaecol. 2023 Dec;43(2):2287125. doi: 10.1080/01443615.2023.2287125. Epub 2023 Dec 9.
9
Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.应用母体外周血游离 DNA 低深度全基因组测序技术进行非侵入性产前检测胎儿染色体非整倍体:单中心 1982 例连续病例的回顾性研究
Ultrasound Obstet Gynecol. 2014 Mar;43(3):254-64. doi: 10.1002/uog.13277. Epub 2014 Feb 10.
10
Expanded non-invasive prenatal testing offers better detection of fetal copy number variations but not chromosomal aneuploidies.扩展的无创产前检测能更好地检测胎儿拷贝数变异,但不能检测染色体非整倍体。
PLoS One. 2025 Jan 24;20(1):e0312184. doi: 10.1371/journal.pone.0312184. eCollection 2025.

本文引用的文献

1
Performance analysis of non-invasive prenatal testing for trisomy 13, 18, and 21: A large-scale retrospective study (2018-2021).13、18和21三体综合征无创产前检测的性能分析:一项大规模回顾性研究(2018 - 2021年)
Heliyon. 2024 Jun 22;10(13):e33437. doi: 10.1016/j.heliyon.2024.e33437. eCollection 2024 Jul 15.
2
Genetic counseling of non-invasive prenatal testing (NIPT) trisomy 7-positive pregnancies.非侵入性产前检测(NIPT)7 三体阳性妊娠的遗传咨询。
Taiwan J Obstet Gynecol. 2024 May;63(3):293-296. doi: 10.1016/j.tjog.2024.03.003.
3
Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care.循环游离DNA检测与分析技术进展在患者护理个性化医疗中的应用
Biomolecules. 2024 Apr 19;14(4):498. doi: 10.3390/biom14040498.
4
Supporting patient decision-making in non-invasive prenatal testing: a comparative study of professional values and practices in England and France.支持非侵入性产前检测中的患者决策:英格兰和法国的专业价值观和实践比较研究。
BMC Med Ethics. 2024 Mar 21;25(1):34. doi: 10.1186/s12910-024-01032-0.
5
Reasons for failure of noninvasive prenatal test for cell-free fetal DNA in maternal peripheral blood.母体外周血游离胎儿 DNA 无创产前检测失败的原因。
Mol Genet Genomic Med. 2024 Jan;12(1):e2351. doi: 10.1002/mgg3.2351.
6
Psychological impact of additional findings detected by genome-wide Non-Invasive Prenatal Testing (NIPT): TRIDENT-2 study.全基因组无创产前检测(NIPT)发现的额外结果的心理影响:TRIDENT-2研究
Eur J Hum Genet. 2024 Mar;32(3):302-308. doi: 10.1038/s41431-023-01504-8. Epub 2023 Dec 7.
7
Non-invasive prenatal testing: a revolutionary journey in prenatal testing.无创产前检测:产前检测领域的革命性历程。
Front Med (Lausanne). 2023 Nov 9;10:1265090. doi: 10.3389/fmed.2023.1265090. eCollection 2023.
8
Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss.早孕期自然流产中染色体异常的发生率。
Nat Med. 2023 Dec;29(12):3233-3242. doi: 10.1038/s41591-023-02645-5. Epub 2023 Nov 23.
9
A decade of change - lessons learned from prenatal diagnostics in Central Denmark region in 2008-2018.一个十年的变革——2008-2018 年丹麦中部地区产前诊断的经验教训。
Acta Obstet Gynecol Scand. 2023 Nov;102(11):1505-1510. doi: 10.1111/aogs.14631. Epub 2023 Jul 21.
10
The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: A systematic review and meta-analysis.产前游离DNA筛查性染色体异常的准确性:一项系统评价和荟萃分析。
Am J Obstet Gynecol MFM. 2023 Mar;5(3):100844. doi: 10.1016/j.ajogmf.2022.100844. Epub 2022 Dec 24.

克罗地亚十年无创产前检测(NIPT)用于染色体异常检测:为该国未来产前护理策略提供信息的首个全国单中心研究

A Decade of Non-Invasive Prenatal Testing (NIPT) for Chromosomal Abnormalities in Croatia: First National Monocentric Study to Inform Country's Future Prenatal Care Strategy.

作者信息

Podobnik Petra, Meštrović Tomislav, Đorđević Aida, Kurdija Kristian, Jelčić Dženis, Ogrin Nina, Bertović-Žunec Ivan, Gebauer-Vuković Beata, Hočevar Grega, Lončar Igor, Srebreniković Zlata, Trobina Petra, Bitenc Marko, Dumić-Čule Ivo

机构信息

Podobnik Special Hospital, Ul. Sveti Duh 112, 10000 Zagreb, Croatia.

DA VINCI Polyclinic, Petrovaradinska ulica 110, 10000 Zagreb, Croatia.

出版信息

Genes (Basel). 2024 Dec 11;15(12):1590. doi: 10.3390/genes15121590.

DOI:10.3390/genes15121590
PMID:39766857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11675109/
Abstract

BACKGROUND

Chromosomal numerical and structural alterations are significant causes of various developmental disorders in foetuses. Non-invasive prenatal testing (NIPT) has emerged as an effective screening tool for detecting common aneuploidies, aiding in the identification of individuals who may require further diagnostic work-up.

METHODS

This retrospective, monocentric observational study evaluates the usage patterns, test choices, turnaround times (TAT), and outcomes of NIPT between 2013 and 2023 on a sample of 2431 pregnant women at a special hospital offering outpatient services and comprehensive gynaecological/obstetric inpatient care. We analysed the trends in NIPT usage, high-risk results, prior screening procedures, as well as factors such as age, gestational age and in vitro fertilisation (IVF) status. NIPT was performed using cell-free foetal DNA (cffDNA) extracted from maternal plasma, followed by library construction, sequencing and result analysis. The sequencing results were aligned with reference genomes, and z-scores were calculated to assess the likelihood of aneuploidy. Statistical significance was set at < 0.05.

RESULTS

The average age of women undergoing NIPT decreased from 36.1 years in 2013 to 33.01 years in 2023 ( = 0.0287), and mean TAT dropped from 12.44 days in 2013 to 7.08 days in 2023 ( = 0.0121), with the most substantial reduction occurring between 2013 and 2019. The study identified a stable rate of women who underwent IVF seeking prenatal testing, with no statistically significant difference between the first half and the second half of the analysed period ( = 0.2659). Among high-risk results, there were 39 chromosomal abnormalities detected, most of them belonging to trisomy 21 (59%).

CONCLUSIONS

Our findings demonstrate the increasing efficiency and accessibility of NIPT in prenatal care in Croatia, while the significant reduction in TAT and the decreasing age of women undergoing NIPT reflect enhanced operational practices and broader acceptance. Introducing NIPT into the public healthcare system in the Republic of Croatia could improve equitable access to advanced prenatal care and enhance pregnancy outcomes. Future advancements in technology and genetic counselling will further enhance its role, requiring careful attention to ethical and regulatory considerations.

摘要

背景

染色体数目和结构改变是胎儿各种发育障碍的重要原因。无创产前检测(NIPT)已成为检测常见非整倍体的有效筛查工具,有助于识别可能需要进一步诊断检查的个体。

方法

这项回顾性、单中心观察性研究评估了2013年至2023年期间,在一家提供门诊服务以及全面妇科/产科住院护理的专科医院中,2431名孕妇样本的NIPT使用模式、检测选择、周转时间(TAT)和结果。我们分析了NIPT使用趋势、高危结果、先前的筛查程序,以及年龄、孕周和体外受精(IVF)状态等因素。使用从母血血浆中提取的游离胎儿DNA(cffDNA)进行NIPT,随后进行文库构建、测序和结果分析。将测序结果与参考基因组比对,并计算z值以评估非整倍体的可能性。设定统计学显著性为<0.05。

结果

接受NIPT的女性平均年龄从2013年的36.1岁降至2023年的33.01岁( = 0.0287),平均TAT从2013年的12.44天降至2023年的7.08天( = 0.0121),最大降幅发生在2013年至2019年之间。该研究发现寻求产前检测的IVF女性比例稳定,分析期的上半年和下半年之间无统计学显著差异( = 0.2659)。在高危结果中,检测到39例染色体异常,其中大多数属于21三体(59%)。

结论

我们的研究结果表明,在克罗地亚的产前护理中,NIPT的效率和可及性不断提高,而TAT的显著缩短以及接受NIPT的女性年龄的降低反映了操作实践的改进和更广泛的接受度。将NIPT引入克罗地亚共和国的公共医疗系统可以改善公平获得先进产前护理的机会并提高妊娠结局。技术和遗传咨询方面的未来进展将进一步增强其作用,需要仔细关注伦理和监管考量。